http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102772795-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10 |
| filingDate | 2012-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102772795-B |
| titleOfInvention | The application of brucella flagellin BMEII1112 in preparation brucella subunit vaccine |
| abstract | The invention provides the novelty teabag of a kind of brucella flagellin BMEII1112 in preparation brucella subunit vaccine.Experimental result shows that BMEII1112 recombiant protein and Freund adjuvant combined immunization can the antibody of inducing producing specificity, activated cell immunity, and has good immune protective effect to brucella, can be used for preparation brucella subunit vaccine.The present invention will play a significant role in brucellar epidemic prevention, have a extensive future. |
| priorityDate | 2012-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.